Results 121 to 130 of about 159,798 (214)

Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β₂-Agonist-Only Treatment. [PDF]

Am J Respir Crit Care Med, 2022
Baraldi E, Piacentini G.
europepmc   +1 more source

Angiotensin‐converting enzyme and exercise adaptations: Genetic variability, pharmacological modulation and future directions

The Journal of Physiology, EarlyView.
Abstract figure legend ACE I/D genotype, enzyme activity and integrated physiological adaptations. Upper panel: Conceptual framework linking the ACE I/D polymorphism (left) with circulating/tissue ACE activity (centre; violin plots based on hypothetical data for illustration) and strength/power versus endurance phenotypes (right).
Tórur Sjúrðarson, Nikolai B. Nordsborg   +1 more
wiley   +1 more source

Optimizing the Use of Inhaled Corticosteroid/Long-Acting β₂-Agonist Combinations in Patients with Moderate-to-Severe Asthma. [PDF]

Adv Ther
Garcia G, Maneechotesuwan K, Krishnan P, Verma M, Roche N.   +4 more
europepmc   +1 more source

Short-acting β₂-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III. [PDF]

BMC Pulm Med, 2022
Yorgancıoğlu A, Aksu K, Naycı SA, Ediger D, Mungan D, Gül U, Beekman MJHI, SABINA Turkey Study Group.   +7 more
europepmc   +1 more source

Anatomical and functional mapping of vagal nociceptive sensory nerve subsets innervating the mouse lower airways by intersectional genetics

The Journal of Physiology, EarlyView.
Abstract figure legend We used an intersectional approach with recombinase‐expressing mice and adeno‐associated virus to map and modulate distinct nociceptive afferents in the vagal ganglia. TRPV1+P2X2+ neurons resided in the nodose ganglion (N), innervated the lungs (many projected into the alveoli) but not the trachea, and projected to the nucleus ...
Mayur J. Patil, Justin Shane Hooper, Seol‐Hee Kim, Parmvir K. Bahia, Nika Pavelkova, Sanjay S. Nair, Teresa S. Darcey, Karina V. Lurye, Meghana Madaram, Jailene Fiallo, Stephen H. Hadley, Thomas E. Taylor‐Clark   +11 more
wiley   +1 more source

Predicting mortality with machine learning & biomarkers: A cohort analysis from aerosolized β₂-agonist for treatment of acute lung injury (ALTA) trial. [PDF]

Physiol Rep
Chase AM, Almuntashiri S, Zhang D, Jones TW, Chen X, Somanath PR, Henry K, Sikora A.   +7 more
europepmc   +1 more source

Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β₂-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. [PDF]

Int J Chron Obstruct Pulmon Dis, 2023
Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS.   +12 more
europepmc   +1 more source

Potential health benefits of cold‐water immersion: the central role of PGC‐1α

The Journal of Physiology, EarlyView.
Abstract figure legend Cold‐water immersion (CWI) elicits autonomic, somato‐motoric (shivering thermogenesis), endocrine and metabolic, sensory transduction, and local biophysical effects that may converge on the transcriptional co‐activator PGC‐1α (centre).
Erich Hohenauer, Wafa Douzi, Johannes Burtscher   +2 more
wiley   +1 more source

ROS-mediated regulation of β2AR function: Does oxidation play a meaningful role towards β2-agonist tachyphylaxis in airway obstructive diseases? [PDF]

Biochem Pharmacol
Teyani RL, Moghaddam F, Moniri NH.
europepmc   +1 more source

A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease. [PDF]

BMC Pulm Med, 2021
Muraki M, Kunita Y, Shirahase K, Yamazaki R, Hanada S, Sawaguchi H, Tohda Y.   +6 more
europepmc   +1 more source